Brazil Implements Ban on E-cigarettes and Offers Free Treatment

Regulations by 2FIRSTS.ai

Apr.30.2024

Brazil Implements Ban on E-cigarettes and Offers Free Treatment

Brazil bans production, import, sale, distribution, storage, transport, and advertising of e-cigarettes. Free treatment plans provided by national health system.

According to a report by Bonde on April 29, the Brazilian National Health Surveillance Agency (Anvisa) has implemented a ban on the production, importation, sale, distribution, storage, transportation, and promotion of e-cigarettes.

In order to comply with this ban, Rejane Cristina, head of the smoking control division at the Ministry of Health, emphasized that the Brazilian National Health System (SUS) will provide free treatment programs utilizing cognitive behavioral therapy, support materials, and when appropriate, Nicotine Replacement Therapy (NRT) medication including patches, gum, and non-nicotine treatments such as bupropion.

There are treatment methods available, but people need to understand that they have a chemical dependence. We understand the difficulty of seeking treatment, but quitting smoking at any time will bring benefits.

References:

[1] Anvisa proíbe a fabricação e venda de "vapes" e reforça disponibilidade de tratamento pelo SUS

Also Read:

[1] Brazilian Police Seize Illegal E-cigarettes with THC Worth $39,085

[2] Brazil's Federal Revenue Agency Seizes 1.37 Million Smuggled E-cigarettes

[3] Brazil Bans E-cigarette Devices in Effort to Protect Public Health

[4] Brazilian Senator Soraya Thronicke Opposes Anvisa's E-Cigarette Ban

#Legislation #Open system e-cigarettes #Regulation #South America #Brazil #Nicotine-free e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry

Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.

Nov.24

WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade

The Fourth Meeting of the Parties (MOP4) to the Protocol to Eliminate Illicit Trade in Tobacco Products opened in Geneva on November 24, 2025. With 60 Parties participating, the meeting focuses on strengthening legal action and international cooperation to combat illicit trade, which accounts for about 11% of the global tobacco market and costs governments billions in lost tax revenue.

Nov.25 by 2FIRSTS.ai

FCTC: Global tobacco control treaties to address nicotine addiction, tobacco’s impact on the environment and illicit tobacco trade

More than 1,400 delegates will gather in Geneva as two major global tobacco control treaties convene to address rising nicotine addiction, environmental harms, and illicit tobacco trade—key discussions that could shape the future of global tobacco control policy.

Nov.14

Wales Passes Law Banning Tobacco Sales to Anyone Born After 2009

The Welsh Parliament (Senedd) has approved new legislation banning tobacco sales to anyone born on or after January 1, 2009. The law, passed on December 9, 2025, also imposes stricter controls on how vapes and nicotine products are advertised and sold. Designed by the UK Government but voted on separately in Wales, the bill passed with 36 votes in favor, two abstentions, and nine against. It grants stronger enforcement powers to Trading Standards to combat illegal tobacco and vape sales.